Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 3 of 28
-
Brazilian Community-Based Organization ABIA Bids to Expand HIV Treatment Access by Overriding the Patent on Dolutegravir
The Brazilian Interdisciplinary AIDS Association (ABIA), an advocacy group in Rio de Janeiro, has called on the Ministry of Health...
-
People’s Resolution: A Roadmap to Protect the Right to Life in a Failed Multilateral Order
We, as members of communities, civil society and activists affected by epidemics, call for a plan of action to end...
-
Researchers Reveal Strategies Used by Big Pharma to Monopolize COVID-19 Drugs and Vaccines
Pharmaceutical companies took advantage of the COVID-19 pandemic, ensuring maximum profits and monopolies on life-saving vaccines and drugs, according to...
-
FGEP Files Pre-Grant Patent Opposition for Covid Vaccine Against Pfizer
Fundación Grupo Efecto Positivo (FGEP) has filed a pre-grant patent opposition in a bid to make COVID-19 vaccines accessible and...
-
Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
Activists from Morocco, Thailand, and Vietnam have filed patent oppositions to challenge drug manufacturers Incyte and Eli Lilly over the...
-
J & J’s Deal With the Global Drug Facility Disguises the Continued Issue with Access to Bedaquiline to Treat Drug-Resistant Tuberculosis
“This deal is big step backwards for global public health – it allows J & J to keep selling higher-priced...
-
The pandemic is declared finished, but the fight for access never stops
MMA consortium members from Argentina, Brazil, Thailand and EECA region, took action to secure access to molnupiravir. In Argentina, the...
-
Being ahead of the curve: access to Delamanid in Thailand
MMA’s consortium partner, the Thai Network of People Living with HIV/AIDS (TNP+), has filed a third-party observation on a patent...
-
Civil Society Organizations in Brazil fight for better access to Dolutegravir
Brazilian Interdisciplinary AIDS Association (ABIA), along with the Working Group on Intellectual Property (GTPI) of the Brazilian Network for the...
-
Paxlovid in the post pandemic world
The World Health Organization (WHO) recently declared that COVID-19 is “…now an established and ongoing health issue which no longer...
-
Hurdles and opportunities for Hepatitis C treatment in Thailand
Kularb Dangtong is the leader of a comprehensive HIV continuum of care center (CCC Center) in Thailand. CCC Centers are...
-
Patent-free, low-cost vaccines highly protective against severe COVID
A new analysis of 390,459 participants assessing 14 different COVID-19 vaccines has identified no significant difference in efficacy against both symptomatic and severe...
